A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

The diabetes team at Shropshire's main hospital trust has been honoured with a special award voted for by members of the ...

Earlier this year, Tandem Diabetes Care announced a voluntary correction for certain t:slim X2 insulin pumps after identifying a potential defect that could interrupt insulin delivery and pose health ...

SCRANTON, Pa. — On Saturday, runners laced up their sneakers for the second annual diabetes five-k and walk in Lackawanna ...

Can one molecule replace separate insulin and glucagon shots in Type 1 diabetes? New research shows it might be possible.

The United States Rapid Acting Insulin Market is poised for significant growth, increasing from US$ 2.32 Billion in 2024 to US$ 3.40 Billion by 2033, with a CAGR of 4.33%. Key growth drivers include ...

Among 91 women, those who used a closed-loop insulin delivery system spent an average of 65.4% of time in pregnancy-specific ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

The new substance combines both insulin, the hormone that lowers blood sugar levels—and glucagon, which that increases them.